Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Abstract Background Evidence and guidelines for Non-vitamin K antagonist oral anticoagulants (NOACs) use when prescribing concurrent rifampin for tuberculosis treatment in patients with non-valvular atrial fibrillation (NVAF) are limited. Methods Using the Korean National Health Insurance Service da...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2023-04-01
|
| Reeks: | BMC Cardiovascular Disorders |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s12872-023-03212-z |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
